Document:

EX-4.1

 Exhibit 4.1 

DESCRIPTION OF SECURITIES 
 The
following is a summary of the material terms of our securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of December 31, 2021, and provisions of our amended and
restated certificate of incorporation and bylaws. The summary is subject to and qualified in its entirely by reference to the amended and restated certificate of incorporation and bylaws, each of which is filed as an exhibit to the Annual Report on
Form 10-K. The following also summarizes certain provisions of the General Corporation Law of the State of Delaware (the “DGCL”) and is subject to and qualified in its entirely by reference to the
DGCL. References in this report to “we,” “us” or the “Company” refer to RXR Acquisition Corp., a Delaware corporation. Capitalized terms used but not defined herein have the meanings given to them in the Annual Report
on Form 10-K. 
 General 

Pursuant to our amended and restated certificate of incorporation, we are authorized to issue 275,000,000 shares of common stock, $0.0001 par value each,
including 250,000,000 shares of Class A common stock and 25,000,000 shares of Class B common stock, as well as 2,500,000 shares of preferred stock, $0.0001 par value each. The following description summarizes certain terms of our capital
stock as set out more particularly in our amended and restated certificate of incorporation. Because this description is only a summary, it may not contain all the information that is important to you. 

Units 
 Each unit consists of one share of Class A
common stock and one-fifth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment as
described herein. 
 Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of the shares of Company’s
Class A common stock. This means only a whole warrant may be exercised at any given time by a warrant holder. For example, if a warrant holder holds one-fifth of one warrant to purchase a share of
Class A common stock, such warrant will not be exercisable. If a warrant holder holds five-fifths of one warrant, such whole warrant will be exercisable for one share of Class A common stock at a price of $11.50 per share. The Class A
common stock and warrants comprising the units began separate trading on April 26, 2021. Holders have the option to continue to hold units or separate their units into the component securities. Holders will need to have their brokers contact
our transfer agent in order to separate the units into Class A common stock and warrants. No fractional warrants were issued upon separation of the units and only whole warrants trade. Accordingly, unless you purchase at least five units, you
will not be able to receive or trade a whole warrant. 
 Listing of Securities 

We have been approved to list our units on Nasdaq under the symbol “RXRAU,” the Class A common stock under the symbol “RXRA” and
warrants under the symbol “RXRAW.” 
 Common Stock 

As of March 21, 2022, 34,500,000 shares of our Class A common stock and 8,625,000 shares of Class B common stock (the “founder shares”)
were outstanding. 
 Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of
Class A common stock and holders of Class B common stock vote together as a single class on all matters submitted to a vote of our stockholders except as required by law. 

 Unless specified in our amended and restated certificate of incorporation, or as required by applicable
provisions of the DGCL or applicable stock exchange rules, the affirmative vote of a majority of our shares of common stock that are voted is required to approve any such matter voted on by our stockholders. There is no cumulative voting with
respect to the election of directors, with the result that the holders of more than 50% of the shares voted for the election of directors can elect all of the directors. 

Our stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor. 

Because our amended and restated certificate of incorporation authorizes us to issue up to 250,000,000 shares of Class A common stock, if we were to
enter into a business combination, we may (depending on the terms of such a business combination) be required to increase the number of shares of Class A common stock which we are authorized to issue at the same time as our stockholders vote on
the business combination to the extent we seek stockholder approval in connection with our initial business combination. 
 In accordance with Nasdaq
corporate governance requirements, we are not required to hold an annual meeting until no later than one year after our first fiscal year end following our listing on Nasdaq. Under Section 211(b) of the DGCL, we are, however, required to hold
an annual meeting of stockholders for the purposes of electing directors in accordance with our bylaws, unless such election is made by written consent in lieu of such a meeting. We may not hold an annual meeting of stockholders to elect new
directors prior to the consummation of our initial business combination, and thus we may not be in compliance with Section 211(b) of the DGCL, which requires an annual meeting. Therefore, if our stockholders want us to hold an annual meeting
prior to the consummation of our initial business combination, they may attempt to force us to hold one by submitting an application to the Delaware Court of Chancery in accordance with Section 211(c) of the DGCL. 

We will provide our public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business
combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of our initial business
combination, including interest (less amounts released to us to pay our taxes), divided by the number of then outstanding public shares, subject to the limitations described herein. The per share amount we will distribute to investors who properly
redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriters. The redemption rights include the requirement that any beneficial owner on whose behalf a redemption right is being exercised must
identify itself in order to validly redeem its shares. Our sponsor, officers and directors have entered into a letter agreement with us pursuant to which they have agreed to waive their redemption rights in connection with the completion of our
initial business combination with respect to any founder shares and public shares they hold. Unlike many special purpose acquisition companies that hold stockholder votes and conduct proxy solicitations in conjunction with their initial business
combinations and provide for related redemptions of public shares for cash upon completion of such initial business combinations even when a vote is not required by law, if a stockholder vote is not required by law and we do not decide to hold a
stockholder vote for business or other legal reasons, we will, pursuant to our amended and restated certificate of incorporation, conduct the redemptions pursuant to the tender offer rules of the SEC, and file tender offer documents with the SEC
prior to completing our initial business combination. Our amended and restated certificate of incorporation requires these tender offer documents to contain substantially the same financial and other information about our initial business
combination and the redemption rights as is required under the SEC’s proxy rules. If, however, a stockholder approval of the transaction is required by law, or we decide to obtain stockholder approval for business or other legal reasons, we
will, like many special purpose acquisition companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If we seek stockholder approval, we will complete our
initial business combination only if a majority of the shares of common stock voted are voted in favor of our initial business combination. However, the participation of our sponsor, officers, directors, advisors or their affiliates in
privately-negotiated transactions, if any, could result in the approval of our initial business combination even if a majority of our public stockholders vote, or indicate their intention to vote, against such initial business combination. For
purposes of seeking approval of the majority of our outstanding shares of common stock, non-votes will have no effect on the approval of our initial business combination once a quorum is obtained. 

 If we seek stockholder approval of our initial business combination and we do not conduct redemptions in
connection with our initial business combination pursuant to the tender offer rules, our amended and restated certificate of incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with
whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to Excess Shares, without our prior consent. However, we will not
restrict our stockholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination. Our stockholders’ inability to redeem the Excess Shares will reduce their influence over our ability
to complete our initial business combination, and such stockholders could suffer a material loss in their investment if they sell such Excess Shares on the open market. Additionally, such stockholders will not receive redemption distributions with
respect to the Excess Shares if we complete our initial business combination. And, as a result, such stockholders will continue to hold that number of shares exceeding 15% and, in order to dispose such shares would be required to sell their shares
in open market transactions, potentially at a loss. 
 If we seek stockholder approval in connection with our initial business combination, our sponsor,
officers and directors have agreed to vote any founder shares they hold and any public shares purchased during or after our initial public offering in favor of our initial business combination. As a result, in addition to our founder shares, we
would need 12,937,501, or 37.5%, of the 34,500,000 public shares outstanding to be voted in favor of an initial business combination in order to have our initial business combination approved (assuming all outstanding shares are voted).
Additionally, each public stockholder may elect to redeem their public shares irrespective of whether they vote for or against the proposed transaction. 

Pursuant to our amended and restated certificate of incorporation, if we do not complete our initial business combination within 24 months from the closing of
our initial public offering, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (less amounts released to us to pay our taxes and up to $100,000 of interest to pay
dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any),
and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Delaware law to
provide for claims of creditors and the requirements of other applicable law. Our sponsor, officers and directors have entered into a letter agreement with us pursuant to which they have agreed to waive their rights to liquidating distributions from
the trust account with respect to their founder shares if we fail to complete our initial business combination within 24 months from the closing of our initial public offering. However, if our sponsor or management team acquire public shares in or
after our initial public offering, they will be entitled to liquidating distributions from the trust account with respect to such public shares if we fail to complete our initial business combination within the prescribed time period. 

In the event of a liquidation, dissolution or winding up of the company after a business combination, our stockholders are entitled to share ratably in all
assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of shares, if any, having preference over the common stock. Our stockholders have no preemptive or other subscription rights.
There are no sinking fund provisions applicable to the common stock, except that we will provide our public stockholders with the opportunity to redeem their public shares for cash at a per share price equal to the aggregate amount then on deposit
in the trust account, including interest (less amounts released to us to pay our taxes), divided by the number of then outstanding public shares, upon the completion of our initial business combination, subject to the limitations described herein.

 Additionally, the units that have not already been separated will automatically separate into their
component parts in connection with the completion of our initial business combination and will no longer be listed thereafter. 
 Founder Shares

 The founder shares are designated as Class B common stock and, except as described below, are identical to the shares of Class A common
stock included in the units, and holders of founder shares have the same stockholder rights as public stockholders, except that (i) the founder shares are subject to certain transfer restrictions, as described in more detail below,
(ii) our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed (A) to waive their redemption rights with respect to any founder shares and public shares they hold in connection
with the completion of our initial business combination, (B) to waive their redemption rights with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to our amended and
restated certificate of incorporation to modify the substance or timing of our obligation to redeem 100% of our public shares if we have not consummated an initial business combination within 24 months from the closing of our initial public offering
or with respect to any other material provisions relating to stockholders’ rights or pre-initial business combination activity and (C) to waive their rights to liquidating distributions from the
trust account with respect to any founder shares they hold if we fail to complete our initial business combination within 24 months from the closing of our initial public offering, although they will be entitled to liquidating distributions from the
trust account with respect to any public shares they hold if we fail to complete our initial business combination within such time period, and (iii) the founder shares are automatically convertible into Class A common stock at the time of
the consummation of our initial business combination on a one-for-one basis, subject to adjustment as described herein and in our amended and restated certificate of
incorporation. If we submit our initial business combination to our public stockholders for a vote, our sponsor, officers and directors have agreed to vote their founder shares and any public shares purchased during or after our initial public
offering in favor of our initial business combination. 
 The founder shares will automatically convert into shares of Class A common stock at the time
of the consummation of our initial business combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations,
recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with our initial business
combination, the number of shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of
Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed
issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the company in connection with or in relation to the consummation of the initial business combination, excluding any shares of
Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial business combination and any private placement warrants
issued to our sponsor, officers or directors upon conversion of working capital loans, provided that such conversion of founder shares will never occur on a less than
one-for-one basis. 
 Subject to certain limited exceptions, the founder
shares are not transferable, assignable or salable (except to our officers and directors and other persons or entities affiliated with our sponsor, each of whom will be subject to the same transfer restrictions) until the earlier of (A) one
year after the completion of our initial business combination or earlier if, subsequent to our initial business combination, the closing price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock
capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, and
(B) the date following the completion of our initial business combination on which we complete a liquidation, merger, capital stock exchange or other similar transaction that results in all of our stockholders having the right to exchange their
Class A common stock for cash, securities or other property. 

 Preferred Stock 

Our amended and restated certificate of incorporation authorizes 2,500,000 shares of preferred stock and provides that shares of preferred stock may be issued
from time to time in one or more series. Our board of directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and
restrictions thereof, applicable to the shares of each series. Our board of directors is able to, without stockholder approval, issue shares of preferred stock with voting and other rights that could adversely affect the voting power and other
rights of the holders of the common stock and could have anti-takeover effects. The ability of our board of directors to issue shares of preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change
of control of us or the removal of existing management. We have no preferred shares outstanding at the date hereof. Although we do not currently intend to issue any shares of preferred stock, we cannot assure you that we will not do so in the
future. 
 Redeemable Warrants 
 Public
Stockholders’ Warrants 
 Each whole warrant entitles the registered holder to purchase one share of Class A common stock at a price of
$11.50 per share, subject to adjustment as discussed below, at any time commencing on the later of 12 months from the closing of our initial public offering and 30 days after the completion of our initial business combination. Pursuant to the
warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares of Class A common stock. This means only a whole warrant may be exercised at a given time by a warrant holder. No fractional warrants will be issued
upon separation of the units and only whole warrants will trade. Accordingly, unless you purchase at least five units, you will not be able to receive or trade a whole warrant. The warrants will expire five years after the completion of our initial
business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. 
 We will not be obligated to deliver any
Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A common stock underlying the
warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below with respect to registration, except if the warrants may be exercised on a “cashless basis” and such
cashless exercise is exempt from registration under the Securities Act. No warrant will be exercisable and we will not be obligated to issue a share of Class A common stock upon exercise of a warrant unless the share of Class A common
stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately
preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will we be required to net cash settle any
warrant. In the event that a registration statement is not effective for the exercised warrants and cashless exercise is unavailable, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the
share of Class A common stock underlying such unit. 
 We have agreed that as soon as practicable, but in no event later than fifteen
(15) business days after the closing of our initial business combination, we will use our commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common
stock issuable upon exercise of the warrants. We will use our commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until
the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of our initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when we will have
failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. 

 Notwithstanding the above, if our Class A common stock are at the time of any exercise of a warrant not
listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, we may, at our option, require holders of public warrants who exercise their warrants
to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, and in the event we do not so
elect, we will use our commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering the warrants
for that number of shares of Class A common stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied by the excess of
the “fair market value” (defined below) less the exercise price of the warrants by (y) the fair market value and (B) 0.361 per whole warrant. The “fair market value” as used in this paragraph shall mean the volume weighted
average price of the shares of Class A common stock for the 10 trading days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent. 

Redemption of Warrants When the Price Per Share of Class A Common Stock Equals or Exceeds $18.00. Once the warrants become
exercisable, we may call the warrants for redemption (except as described herein with respect to the private placement warrants): 
  

	 	•	 in whole and not in part; 

 

	 	•	 at a price of $0.01 per warrant; 

 

	 	•	 upon a minimum of 30 days’ prior written notice of redemption (the
“30-day redemption period”) to each warrant holder; and 

  

	 	•	 if, and only if, the closing price of the common stock equals or exceeds $18.00 per share (as adjusted for
stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send
the notice of redemption to the warrant holders. 

 We will not redeem the warrants as described above unless a registration statement
under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available throughout
the 30-day redemption period. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all
applicable state securities laws. 
 We have established the last redemption criterion discussed above to prevent a redemption call unless there is at the
time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to exercise his, her or its warrant prior to
the scheduled redemption date. However, the price of the Class A common stock may fall below the $18.00 redemption trigger price (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) as well as
the $11.50 warrant exercise price after the redemption notice is issued. 
 Redemption of Warrants When the Price Per Share of Class A
Common Stock Equals or Exceeds $10.00.    Once the warrants become exercisable, we may call the warrants for redemption: 
  

	 	•	 in whole and not in part; 

	 	•	 at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that
holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares to be determined by reference to the table below, based on the redemption date and the “fair market value” of our
Class A common stock (as defined below) except as otherwise described below; and 

  

	 	•	 if, and only if, the closing price of our Class A common stock equals or exceeds
$10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, reclassifications, recapitalizations and the like) for any 20 trading days within the 30-trading day period ending on
the third trading day prior to the date on which we send the notice of redemption to the warrant holders; and if the closing price of the Class A common stock for any 20 trading days within a 30-trading
day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, reclassifications,
recapitalizations and the like), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above. 

Beginning on the date the notice of redemption is given until the warrant are redeemed or exercised, holders may elect to exercise their warrants on a
cashless basis. The numbers in the table below represent the number of shares of Class A common stock that a warrant holder will receive upon exercise in connection with a redemption by us pursuant to this redemption feature, based on the
“fair market value” of our Class A common stock on the corresponding redemption date (assuming holders elect to exercise their warrants and such warrants are not redeemed for $0.10 per warrant), determined for these purposes based on
the volume weighted average price of our Class A common stock for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants, and the number of months that the corresponding
redemption date precedes the expiration date of the warrants, each as set forth in the table below. We will provide our warrant holders with the final fair market value no later than one business day after the
10-trading day period described above ends. 
 Pursuant to the warrant agreement, references above to Class A
common stock shall include a security other than Class A common stock into which the Class A common stock has been converted or exchanged for in the event we are not the surviving company in our initial business combination. The numbers in
the table below will not be adjusted when determining the number of shares of Class A common stock to be issued upon exercise of the warrants if we are not the surviving entity following our initial business combination. 

The stock prices set forth in the column headings of the table below will be adjusted as of any date on which the number of shares issuable upon exercise of a
warrant is adjusted as set forth under the heading “— Anti-dilution Adjustments” below. 
 If the number of shares issuable upon exercise of
a warrant is adjusted, the adjusted share prices in the column headings will equal the share prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the number of shares deliverable upon exercise of a warrant
immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a warrant as so adjusted. The number of shares in the table below shall be adjusted in the same manner and at the same time as the
number of shares issuable upon exercise of a warrant. If the exercise price of a warrant is adjusted, (a) in the case of an adjustment pursuant to the fifth paragraph under the heading “— Anti-Dilution Adjustments” below, the
adjusted share prices in the column headings will equal the unadjusted share price multiplied by a fraction, the numerator of which is the higher of the Market Value and the Newly Issued Price as set forth under the heading “—
Anti-Dilution Adjustments” and the denominator of which is $10.00 and (b) in the case of an adjustment pursuant to the second paragraph under the heading “— Anti-Dilution Adjustments” below, the adjusted share prices in the
column headings will equal the unadjusted share price less the decrease in the exercise price of a warrant pursuant to such exercise price adjustment. 

																																					
	 Redemption Date 
(period to expiration 
of
warrants)
	  	Redemption Fair Market Value of Class A Common Stock	 
	  	≤$10.00	 	  	$11.00	 	  	$12.00	 	  	$13.00	 	  	$14.00	 	  	$15.00	 	  	$16.00	 	  	$17.00	 	  	≥$18.00	 
	 60 months
	  	 	0.261	 	  	 	0.281	 	  	 	0.297	 	  	 	0.311	 	  	 	0.324	 	  	 	0.337	 	  	 	0.348	 	  	 	0.358	 	  	 	0.361	 
	 57 months
	  	 	0.257	 	  	 	0.277	 	  	 	0.294	 	  	 	0.310	 	  	 	0.324	 	  	 	0.337	 	  	 	0.348	 	  	 	0.358	 	  	 	0.361	 
	 54 months
	  	 	0.252	 	  	 	0.272	 	  	 	0.291	 	  	 	0.307	 	  	 	0.322	 	  	 	0.335	 	  	 	0.347	 	  	 	0.357	 	  	 	0.361	 
	 51 months
	  	 	0.246	 	  	 	0.268	 	  	 	0.287	 	  	 	0.304	 	  	 	0.320	 	  	 	0.333	 	  	 	0.346	 	  	 	0.357	 	  	 	0.361	 
	 48 months
	  	 	0.241	 	  	 	0.263	 	  	 	0.283	 	  	 	0.301	 	  	 	0.317	 	  	 	0.332	 	  	 	0.344	 	  	 	0.356	 	  	 	0.361	 
	 45 months
	  	 	0.235	 	  	 	0.258	 	  	 	0.279	 	  	 	0.298	 	  	 	0.315	 	  	 	0.330	 	  	 	0.343	 	  	 	0.356	 	  	 	0.361	 
	 42 months
	  	 	0.228	 	  	 	0.252	 	  	 	0.274	 	  	 	0.294	 	  	 	0.312	 	  	 	0.328	 	  	 	0.342	 	  	 	0.355	 	  	 	0.361	 
	 39 months
	  	 	0.221	 	  	 	0.246	 	  	 	0.269	 	  	 	0.290	 	  	 	0.309	 	  	 	0.325	 	  	 	0.340	 	  	 	0.354	 	  	 	0.361	 
	 36 months
	  	 	0.213	 	  	 	0.239	 	  	 	0.263	 	  	 	0.285	 	  	 	0.305	 	  	 	0.323	 	  	 	0.339	 	  	 	0.353	 	  	 	0.361	 
	 33 months
	  	 	0.205	 	  	 	0.232	 	  	 	0.257	 	  	 	0.280	 	  	 	0.301	 	  	 	0.320	 	  	 	0.337	 	  	 	0.352	 	  	 	0.361	 
	 30 months
	  	 	0.196	 	  	 	0.224	 	  	 	0.250	 	  	 	0.274	 	  	 	0.297	 	  	 	0.316	 	  	 	0.335	 	  	 	0.351	 	  	 	0.361	 
	 27 months
	  	 	0.185	 	  	 	0.214	 	  	 	0.242	 	  	 	0.268	 	  	 	0.291	 	  	 	0.313	 	  	 	0.332	 	  	 	0.350	 	  	 	0.361	 
	 24 months
	  	 	0.173	 	  	 	0.204	 	  	 	0.233	 	  	 	0.260	 	  	 	0.285	 	  	 	0.308	 	  	 	0.329	 	  	 	0.348	 	  	 	0.361	 
	 21 months
	  	 	0.161	 	  	 	0.193	 	  	 	0.223	 	  	 	0.252	 	  	 	0.279	 	  	 	0.304	 	  	 	0.326	 	  	 	0.347	 	  	 	0.361	 
	 18 months
	  	 	0.146	 	  	 	0.179	 	  	 	0.211	 	  	 	0.242	 	  	 	0.271	 	  	 	0.298	 	  	 	0.322	 	  	 	0.345	 	  	 	0.361	 
	 15 months
	  	 	0.130	 	  	 	0.164	 	  	 	0.197	 	  	 	0.230	 	  	 	0.262	 	  	 	0.291	 	  	 	0.317	 	  	 	0.342	 	  	 	0.361	 
	 12 months
	  	 	0.111	 	  	 	0.146	 	  	 	0.181	 	  	 	0.216	 	  	 	0.250	 	  	 	0.282	 	  	 	0.312	 	  	 	0.339	 	  	 	0.361	 
	 9 months
	  	 	0.090	 	  	 	0.125	 	  	 	0.162	 	  	 	0.199	 	  	 	0.237	 	  	 	0.272	 	  	 	0.305	 	  	 	0.336	 	  	 	0.361	 
	 6 months
	  	 	0.065	 	  	 	0.099	 	  	 	0.137	 	  	 	0.178	 	  	 	0.219	 	  	 	0.259	 	  	 	0.296	 	  	 	0.331	 	  	 	0.361	 
	 3 months
	  	 	0.034	 	  	 	0.065	 	  	 	0.104	 	  	 	0.150	 	  	 	0.197	 	  	 	0.243	 	  	 	0.286	 	  	 	0.326	 	  	 	0.361	 
	 0 months
	  	 	—  	 	  	 	—  	 	  	 	0.042	 	  	 	0.115	 	  	 	0.179	 	  	 	0.233	 	  	 	0.281	 	  	 	0.323	 	  	 	0.361	 

 The exact fair market value and redemption date may not be set forth in the table above, in which case, if the fair market
value is between two values in the table or the redemption date is between two redemption dates in the table, the number of Class A common stock to be issued for each warrant exercised will be determined by a straight-line interpolation between
the number of shares set forth for the higher and lower fair market values and the earlier and later redemption dates, as applicable, based on a 365- or 366-day year, as
applicable. For example, if the volume weighted average price of our Class A common stock during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of the warrants is $11 per share, and
at such time there are 57 months until the expiration of the warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for 0.277 Class A common stock for each whole warrant. For an example where the
exact fair market value and redemption date are not as set forth in the table above, if the volume weighted average price of our Class A common stock during the 10 trading days immediately following the date on which the notice of redemption is
sent to the holders of the warrants is $13.50 per share, and at such time there are 38 months until the expiration of the warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for 0.298 Class A
common stock for each whole warrant. In no event will the warrants be exercisable on a cashless basis in connection with this redemption feature for more than 0.361 shares of Class A common stock per warrant (subject to adjustment). 

 Finally, as reflected in the table above, if the warrants are out of the money and about to expire, they
cannot be exercised on a cashless basis in connection with a redemption by us pursuant to this redemption feature, since they will not be exercisable for any shares of Class A common stock. 

This redemption feature differs from the warrant redemption features used in other blank check offerings, which only provide for a redemption of warrants for
cash (other than the private placement warrants) when the trading price for the Class A common stock exceeds $18.00 per share for a specified period of time. This redemption feature is structured to allow for all of the outstanding warrants to
be redeemed when the Class A common stock are trading at or above $10.00 per share, which may be at a time when the trading price of our Class A common stock is below the exercise price of the warrants. We have established this redemption
feature to provide us with the flexibility to redeem the warrants without the warrants having to reach the $18.00 per share threshold set forth above under “— Redemption of Warrants When the Price Per Share of Class A Common Stock
Equals or Exceeds $18.00.” Holders choosing to exercise their warrants in connection with a redemption pursuant to this feature will, in effect, receive a number of shares for their warrants based on an option pricing model with a fixed
volatility input as of March 4, 2021. This redemption right provides us with an additional mechanism by which to redeem all of the outstanding warrants, and therefore have certainty as to (i) our capital structure as the warrants would no
longer be outstanding and would have been exercised or redeemed and (ii) the amount of cash provided by the exercise of the warrants and available to use, and also provides a ceiling to the theoretical value of the warrants as it locks in the
amount of shares we would pay to warrant holders that exercise if we choose to redeem the warrants in this manner. We will be required to pay the applicable redemption price to warrant holders if we choose to exercise this redemption right and it
will allow us to quickly proceed with a redemption of the warrants if we determine it is in our best interest to do so. As such, we would redeem the warrants in this manner when we believe it is in our best interest to update our capital structure
to remove the warrants and pay the redemption price to the warrant holders. 
 As stated above, we can redeem the warrants when the Class A common
stock are trading at a price starting at $10.00, which is below the exercise price of $11.50, because it will provide certainty with respect to our capital structure and cash position while providing warrant holders with the opportunity to exercise
their warrants on a cashless basis for the applicable number of shares. If we choose to redeem the warrants when the Class A common stock are trading at a price below the exercise price of the warrants, this could result in the warrant holders
receiving fewer Class A common stock than they would have received if they had chosen to wait to exercise their warrants for Class A common stock if and when such Class A common stock were trading at a price higher than the exercise
price of $11.50. 
 No fractional Class A common stock will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a
fractional interest in a share, we will round down to the nearest whole number of Class A common stock to be issued to the holder. If, at the time of redemption, the warrants are exercisable for a security other than the shares of Class A
common stock pursuant to the warrant agreement (for instance, if we are not the surviving company in our initial business combination), the warrants may be exercised for such security. At such time as the warrants become exercisable for a security
other than the Class A common stock, the surviving company will use its commercially reasonable efforts to register under the Security Act the security issuable upon the exercise of the warrants within twenty business days of the closing of an
initial business combination. 
 Other Provisions. A holder of a warrant may notify us in writing in the event it elects to be subject to a
requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual knowledge, would
beneficially own in excess of 4.9% or 9.8% (as specified by the holder) of the Class A common stock outstanding immediately after giving effect to such exercise. 

 Anti-Dilution Adjustments. If the number of outstanding shares of Class A common stock is
increased by a share capitalization payable in shares of Class A common stock, or by a split-up of common stock or other similar event, then, on the effective date of such share capitalization, split-up or similar event, the number of shares of Class A common stock issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding shares of common stock. A rights
offering to holders of common stock entitling holders to purchase Class A common stock at a price less than the “historical fair market value” (as defined below) will be deemed a share capitalization of a number of shares of
Class A common stock equal to the product of (i) the number of shares of Class A common stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into
or exercisable for Class A common stock) multiplied by and (ii) one (1) minus the quotient of (x) the price per share of Class A common stock paid in such rights offering and (y) the historical fair market value. For
these purposes (i) if the rights offering is for securities convertible into or exercisable for shares of Class A common stock, in determining the price payable for Class A common stock, there will be taken into account any
consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “historical fair market value” means the volume weighted average price of shares of Class A common stock as reported
during the ten (10) trading day period ending on the trading day prior to the first date on which the Class A common stock trades on the applicable exchange or in the applicable market, regular way, without the right to receive such
rights. 
 In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or
other assets to the holders of Class A common stock on account of such Class A common stock (or other securities into which the warrants are convertible), other than (a) as described above, (b) certain ordinary cash dividends of
$0.50 per annum subject to adjustment, (c) to satisfy the redemption rights of the holders of Class A common stock in connection with a proposed initial business combination including in connection with a vote to extend the time we have to
complete our initial business combination, or (d) in connection with the redemption of our public shares upon our failure to complete our initial business combination, then the warrant exercise price will be decreased, effective immediately
after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each share of Class A common stock in respect of such event. 

If the number of outstanding shares of Class A common stock is decreased by a consolidation, combination, reverse share split or reclassification of
Class A common stock or other similar event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event, the number of shares of Class A common stock issuable on exercise of each
warrant will be decreased in proportion to such decrease in outstanding share of Class A common stock. 
 Whenever the number of shares of Class A
common stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the
numerator of which will be the number of shares of Class A common stock purchasable upon the exercise of the warrants immediately prior to such adjustment, and (y) the denominator of which will be the number of shares of Class A
common stock so purchasable immediately thereafter. 
 In addition, if (x) we issue additional shares of Class A common stock or equity-linked
securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue
price to be determined in good faith by our board of directors and, in the case of any such issuance to our initial stockholders or their affiliates, without taking into account any founder shares held by our initial stockholders or such affiliates,
as applicable, prior to such issuance including any transfer or reissuance of such shares), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the
funding of our initial business combination on the date of the consummation of our initial business combination (net of redemptions), and (z) the volume weighted average trading price of our Class A common stock during the 10 trading day
period starting on the trading day prior to the day on which we consummate our initial business combination is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of
the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price (see “— Redemption of
Warrants When the Price Per Share of Class A Common Stock Equals or Exceeds $18.00” and “— Redemption of Warrants When the Price Per Share of Class A Common Stock Equals or Exceeds $10.00”), and the $10.00 per
share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price (see “— Redemption of Warrants When the Price Per Share of Class A Common Stock Equals or
Exceeds $10.00”). 

 In case of any reclassification or reorganization of the outstanding Class A common stock (other than
those described above or that solely affects the par value of such Class A common stock), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in which we are the continuing
corporation and that does not result in any reclassification or reorganization of our outstanding Class A common stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an
entirety or substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in
lieu of the Class A common stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of Class A common stock or other securities or property (including cash)
receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately
prior to such event. If less than 70% of the consideration receivable by the holders of Class A common stock in such a transaction is payable in the form of Class A common stock in the successor entity that is listed for trading on a
national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if
the registered holder of the warrant properly exercises the warrant within thirty days following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement based on the Black-Scholes
Warrant Value (as defined in the warrant agreement) of the warrant. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of the
warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants. 
 The warrants are issued in
registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure
any ambiguity or correct any defective provision, and that all other modifications or amendments will require the vote or written consent of the holders of at least 50% of the then outstanding public warrants, and, solely with respect to any
amendment to the terms of the private placement warrants, a majority of the then outstanding private placement warrants. 
 The warrants may be exercised
upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment
of the exercise price (or on a cashless basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised. The warrant holders do not have the rights or privileges of holders of common stock and any
voting rights until they exercise their warrants and receive Class A common stock. After the issuance of Class A common stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all
matters to be voted on by stockholders. 
 No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder
would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number the number of shares of Class A common stock to be issued to the warrant holder. 

Exclusive Forum. We have agreed that, subject to applicable law, any action, proceeding or claim against us arising out of or relating in any way to
the warrant agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and we irrevocably submit to such jurisdiction, which jurisdiction
will be the exclusive forum for any such action, proceeding or claim. This provision applies to claims under the Securities Act but does not apply to claims under the Exchange Act or any claim for which the federal district courts of the
United States of America are the sole and exclusive forum. 

 Private Placement Warrants 

The private placement warrants (including the Class A common stock issuable upon exercise of the private placement warrants) will not be transferable,
assignable or salable until 30 days after the completion of our initial business combination (except, among other limited exceptions as described under “Principal Stockholders — Transfers of Founder Shares and Private Placement
Warrants,” to our officers and directors and other persons or entities affiliated with the initial purchasers of the private placement warrants) and they will not be redeemable by us (except as described above under “— Redemption
of Warrants When the Price Per Share of Class A Common Stock Equals or Exceeds $10.00”) so long as they are held by our initial stockholders or their permitted transferees. The sponsor, or its permitted transferees, have the option to
exercise the private placement warrants on a cashless basis. Except as described in this section, the private placement warrants have terms and provisions that are identical to those of the warrants sold as part of the units in our initial public
offering. If the private placement warrants are held by holders other than the initial purchasers or their permitted transferees, the private placement warrants will be redeemable by us in all redemption scenarios and exercisable by the holders on
the same basis as the warrants included in the units sold in our initial public offering. 
 Except as described above under “— Public
Stockholders’ Warrants — Redemption of Warrants When the Price Per Share of Class A Common Stock Equals or Exceeds $10.00,” if holders of the private placement warrants elect to exercise them on a cashless basis, they would pay
the exercise price by surrendering his, her or its warrants for that number of shares of Class A common stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the
warrants, multiplied by the excess of the “sponsor exercise fair market value” of our Class A common stock (defined below) over the exercise price of the warrants by (y) the sponsor exercise fair market value. The “sponsor
exercise fair market value” means the average closing price of the Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent. The
reason that we have agreed that these warrants will be exercisable on a cashless basis so long as they are held by the initial purchasers or their permitted transferees is because it is not known at this time whether they will be affiliated with us
following a business combination. If they remain affiliated with us, their ability to sell our securities in the open market will be significantly limited. We expect to have policies in place that prohibit insiders from selling our securities except
during specific periods of time. Even during such periods of time when insiders will be permitted to sell our securities, an insider cannot trade in our securities if he or she is in possession of material
non-public information. Accordingly, unlike public stockholders who could exercise their warrants and sell the shares of Class A common stock received upon such exercise freely in the open market in order
to recoup the cost of such exercise, the insiders could be significantly restricted from selling such securities. As a result, we believe that allowing the holders to exercise such warrants on a cashless basis is appropriate. 

In order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of
our officers and directors may, but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into warrants of the post business combination entity at a price of $1.50 per warrant at the option of the
lender. Such warrants would be identical to the private placement warrants. 
 Our initial stockholders have agreed not to transfer, assign or sell any of
the private placement warrants (including the Class A common stock issuable upon exercise of any of these warrants) until the date that is 30 days after the date we complete our initial business combination, except that, among other
limited exceptions as described under “Principal Stockholders — Transfers of Founder Shares and Private Placement Warrants,” transfers can be made to our officers and directors and other persons or entities affiliated with the
sponsor. 

 Dividends 

We have not paid any cash dividends on our common stock to date and do not intend to pay cash dividends prior to the completion of a business combination. The
payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of a business combination. The payment of any cash dividends subsequent
to a business combination will be within the discretion of our board of directors at such time. Further, if we incur any indebtedness, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.

 Our Transfer Agent and Warrant Agent 
 The transfer
agent for our common stock and warrant agent for our warrants is Continental Stock Transfer & Trust Company. We have agreed to indemnify Continental Stock Transfer & Trust Company in its roles as transfer agent and warrant agent,
its agents and each of its stockholders, directors, officers and employees against all claims and losses that may arise out of acts performed or omitted for its activities in that capacity, except for any liability due to any gross negligence or
intentional misconduct of the indemnified person or entity. Continental Stock Transfer & Trust Company has agreed that it has no right of set-off or any right, title, interest or claim of any kind to,
or to any monies in, the trust account, and has irrevocably waived any right, title, interest or claim of any kind to, or to any monies in, the trust account that it may have now or in the future. Accordingly, any indemnification provided will only
be able to be satisfied, or a claim will only be able to be pursued, solely against us and our assets outside the trust account and not against the any monies in the trust account or interest earned thereon. 

Amended and Restated Certificate of Incorporation 
 Our
amended and restated certificate of incorporation contains certain requirements and restrictions relating to our initial public offering that will apply to us until the completion of our initial business combination. These provisions cannot be
amended without the approval of the holders of 65% of our common stock. Our initial stockholders, and their permitted transferees, who beneficially own 20% of our common stock upon the closing of our initial public offering (assuming they did not
purchase any units in our initial public offering), may participate in any vote to amend our amended and restated certificate of incorporation and have the discretion to vote in any manner they choose. 

Specifically, our amended and restated certificate of incorporation provides, among other things, that: 

 

	 	•	 If we do not complete our initial business combination within 24 months from the closing of our initial public
offering , we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a
per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (less amounts released to us to pay our taxes and up to $100,000 of interest to pay
dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any),
and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Delaware law to
provide for claims of creditors and in all cases subject to the requirements of other applicable law; 

  

	 	•	 Prior to our initial business combination, we may not issue additional securities that would entitle the
holders thereof to (i) receive funds from the trust account or (ii) vote as a class with our public shares (a) on our initial business combination or (b) to approve an amendment to our amended and restated certificate of
incorporation to (x) extend the time we have to consummate a business combination beyond 24 months from the closing of our initial public offering or (y) amend the foregoing provisions; 

	 	•	 Although we do not intend to enter into a business combination with a target business that is affiliated with
our sponsor, our directors or our executive officers, we are not prohibited from doing so. In the event we enter into such a transaction, we, or a committee of independent directors, will obtain an opinion from an independent investment banking firm
or a valuation or appraisal firm that such a business combination is fair to our company from a financial point of view; 

  

	 	•	 If a stockholder vote on our initial business combination is not required by law and we do not decide to hold a
stockholder vote for business or other legal reasons, we will offer to redeem our public shares pursuant to Rule 13e-4 and Regulation 14E under the Exchange Act, and will file tender offer documents
with the SEC prior to completing our initial business combination which will contain substantially the same financial and other information about our initial business combination and the redemption rights as is required under Regulation 14A
under the Exchange Act. Whether or not we maintain our registration under the Exchange Act or our listing on Nasdaq, we will provide our public stockholders with the opportunity to redeem their public shares by one of the two methods listed above;

  

	 	•	 We must complete one or more business combinations having an aggregate fair market value of at least 80% of the
assets held in the trust account (excluding the deferred underwriting commissions and taxes payable on the income earned on the trust account) at the time of the agreement to enter into the initial business combination; 

 

	 	•	 If our stockholders approve an amendment to our amended and restated certificate of incorporation to modify the
substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of our initial public offering, or with respect to any other material provisions
relating to stockholders’ rights or pre-initial business combination activity, we will provide our public stockholders with the opportunity to redeem all or a portion of their Class A common stock
upon such approval at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (less amounts released to us to pay our taxes), divided by the
number of then outstanding public shares, subject to the limitations described herein; and 

  

	 	•	 We will not effectuate our initial business combination with another blank check company or a similar company
with nominal operations. 

 In addition, our amended and restated certificate of incorporation provides that under no
circumstances will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 upon consummation of our initial business combination and after payment of deferred underwriters’ commission. 

Certain Anti-Takeover Provisions of Delaware Law and our Amended and Restated Certificate of Incorporation and Bylaws 

We are subject to the provisions of Section 203 of the DGCL regulating corporate takeovers. This statute prevents certain Delaware corporations, under
certain circumstances, from engaging in a “business combination” with: 
  

	 	•	 a stockholder who owns 15% or more of our outstanding voting stock (otherwise known as an “interested
stockholder”); 

  

	 	•	 an affiliate of an interested stockholder; or 

 

	 	•	 an associate of an interested stockholder, for three years following the date that the stockholder became an
interested stockholder. 

 A “business combination” includes a merger or sale of more than 10% of our assets. However, the above
provisions of Section 203 do not apply if: 

	 	•	 our board of directors approves the transaction that made the stockholder an “interested
stockholder,” prior to the date of the transaction; 

  

	 	•	 after the completion of the transaction that resulted in the stockholder becoming an interested stockholder,
that stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, other than statutorily excluded shares of common stock; or 

 

	 	•	 on or subsequent to the date of the transaction, the initial business combination is approved by our board of
directors and authorized at a meeting of our stockholders, and not by written consent, by an affirmative vote of at least two-thirds of the outstanding voting stock not owned by the interested stockholder.

 Our authorized but unissued common stock and preferred stock are available for future issuances without stockholder approval and could
be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved common stock and preferred stock could render
more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise. 
 Exclusive forum for
certain lawsuits 
 Our amended and restated certificate of incorporation requires, unless we consent in writing to the selection of an alternative
forum, that (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee to us or our stockholders, (iii) any action
asserting a claim against us, our directors, officers or employees arising pursuant to any provision of the DGCL or our amended and restated certificate of incorporation or bylaws, or (iv) any action asserting a claim against us, our directors,
officers or employees governed by the internal affairs doctrine may be brought only in the Court of Chancery in the State of Delaware, except any claim (A) as to which the Court of Chancery of the State of Delaware determines that there is an
indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), (B) which is vested
in the exclusive jurisdiction of a court or forum other than the Court of Chancery, (C) for which the Court of Chancery does not have subject matter jurisdiction, or (D) any action arising under the Securities Act, as to which the Court of
Chancery and the federal district court for the District of Delaware shall have concurrent jurisdiction. If an action is brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such
stockholder’s counsel. Notwithstanding the foregoing, our amended and restated certificate of incorporation provides that this exclusive forum provision will not apply to suits arising under the Exchange Act or any other claim for which federal
courts have exclusive jurisdiction. 
 Although we believe this provision benefits us by providing increased consistency in the application of Delaware law
in the types of lawsuits to which it applies, a court may determine that this provision is unenforceable, and to the extent it is enforceable, the provision may have the effect of discouraging lawsuits against our directors and officers, although
our stockholders will not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder. 
 Special
meeting of stockholders 
 Our bylaws provide that special meetings of our stockholders may be called only by a majority vote of our board of
directors, by our Chief Executive Officer or by our Chairman. 

 Advance notice requirements for stockholder proposals and director nominations 

Our bylaws provide that stockholders seeking to bring business before our annual meeting of stockholders, or to nominate candidates for election as directors
at our annual meeting of stockholders, must provide timely notice of their intent in writing. To be timely, a stockholder’s notice will need to be received by the company secretary at our principal executive offices not later than the close of
business on the 90th day nor earlier than the opening of business on the 120th day prior to the anniversary date of the immediately preceding
annual meeting of stockholders. Pursuant to Rule 14a-8 under the Exchange Act, proposals seeking inclusion in our annual proxy statement must comply with the notice periods contained therein. Our bylaws
also specify certain requirements as to the form and content of a stockholders’ meeting. These provisions may preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at
our annual meeting of stockholders. 
 Action by written consent 

Any action required or permitted to be taken by our common stockholders must be effected by a duly called annual or special meeting of such stockholders and
may not be effected by written consent of the stockholders other than with respect to our Class B common stock. 
 Class B Common Stock
Consent Right 
 For so long as any shares of Class B common stock remain outstanding, we may not, without the prior vote or written consent of
the holders of a majority of the shares of Class B common stock then outstanding, voting separately as a single class, amend, alter or repeal any provision of our amended and restated certificate of incorporation, whether by merger,
consolidation or otherwise, if such amendment, alteration or repeal would alter or change the powers, preferences or relative, participating, optional or other or special rights of the Class B common stock. Any action required or permitted to
be taken at any meeting of the holders of Class B common stock may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed by the holders of
the outstanding Class B common stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares of Class B common stock were present and voted. 

Securities Eligible for Future Sale 
 We have 43,125,000
shares of common stock outstanding. Of these shares, the 34,500,000 shares of Class A common stock sold in our initial public offering are freely tradable without restriction or further registration under the Securities Act, except for any
Class A common stock purchased by one of our affiliates within the meaning of Rule 144 under the Securities Act. All of the outstanding founder shares and all of the outstanding private placement warrants are restricted securities under
Rule 144, in that they were issued in private transactions not involving a public offering. 
 Rule 144 

Pursuant to Rule 144, a person who has beneficially owned restricted shares or warrants for at least six months would be entitled to sell their securities
provided that (i) such person is not deemed to have been one of our affiliates at the time of, or at any time during the three months preceding, a sale and (ii) we are subject to the Exchange Act periodic reporting requirements for at
least three months before the sale and have filed all required reports under Section 13 or 15(d) of the Exchange Act during the 12 months (or such shorter period as we were required to file reports) preceding the sale. 

Persons who have beneficially owned restricted shares or warrants for at least six months but who are our affiliates at the time of, or at any time during the
three months preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of: 

 

	 	•	 1% of the total number of shares of common stock then outstanding, which will equal 431,250 shares immediately
after our initial public offering; or 

	 	•	 the average weekly reported trading volume of the Class A common stock during the four calendar weeks
preceding the filing of a notice on Form 144 with respect to the sale. 

 Sales by our affiliates under Rule 144 are also
limited by manner of sale provisions and notice requirements and to the availability of current public information about us. 
 Restrictions on the
Use of Rule 144 by Shell Companies or Former Shell Companies 
 Rule 144 is not available for the resale of securities initially issued by
shell companies (other than business combination related shell companies) or issuers that have been at any time previously a shell company. However, Rule 144 also includes an important exception to this prohibition if the following conditions
are met: 
  

	 	•	 the issuer of the securities that was formerly a shell company has ceased to be a shell company;

  

	 	•	 the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the
Exchange Act; 

  

	 	•	 the issuer of the securities has filed all Exchange Act reports and material required to be filed, as
applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and 

 

	 	•	 at least one year has elapsed from the time that the issuer filed current Form 10 type information with
the SEC reflecting its status as an entity that is not a shell company. 

 As a result, our initial stockholders, including our sponsor,
and their permitted transferees, will be able to sell their founder shares and private placement warrants, as applicable, pursuant to Rule 144 without registration one year after we have completed our initial business combination. 

Registration Rights 
 The holders of the (i) founder
shares, which were issued in a private placement prior to the closing of our initial public offering, (ii) private placement warrants, which were issued in a private placement simultaneously with the closing of our initial public offering and
the shares of Class A common stock underlying such private placement warrants and (iii) private placement warrants that may be issued upon conversion of working capital loans have registration rights to require us to register a sale of any
of our securities held by them pursuant to a registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have
certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination. We will bear the expenses incurred in connection with the filing of any such
registration statements. The registration rights agreement will not provide for any maximum cash penalties nor any penalties connected with delays in registering the company’s common stock.Exhibit 10.1

 

VOTING AND STANDSTILL AGREEMENT

 

This Voting and Standstill
Agreement (“Agreement”) is entered into as of March 20, 2022, by and between Spōk Holdings, Inc.,
a Delaware corporation (the “Company”), Braeside Investments, LLC, a Delaware limited liability company, Braeside
Capital, L.P., a Texas limited partnership, and Braeside Capital II, L.P., a Texas limited partnership (collectively, the “Braeside
Parties”) (each of the Company and the Braeside Parties, a “Party” to this Agreement, and collectively,
the “Parties”).

 

RECITALS

 

WHEREAS, the Braeside Parties
have voting power or sole dispositive power or otherwise have beneficial ownership of 1,080,127 shares (the “Current Position”)
of the common stock, par value $0.0001 per share, of the Company (the “Common Stock”) as of the date of this
Agreement; and

 

WHEREAS, as of the date of
this Agreement, the Company and the Braeside Parties have determined to come to an agreement with respect to certain matters set forth
below; and

 

NOW, THEREFORE, in consideration
of the foregoing premises and the mutual covenants and agreements contained herein, and for other good and valuable consideration, the
receipt and sufficiency of which are acknowledged, the Parties to this Agreement, intending to be legally bound, agree as follows:

 

1.      Reduction
in Board Size; Board Nomination. The Nominating and Governance Committee of the Board of Directors of the Company (the “Board”)
and the Board shall take all necessary action to (a) reduce the size of the Board to six (6) directors, consisting of Bobbie
Byrne, Chris Cournoyer, Randy Hyun, Vince Kelly, Brett Shockley and Todd Stein, effective as of immediately prior to the opening of the
polls on the election of directors at the 2022 Annual Meeting of the Company (the “Annual Meeting”) and announce
the foregoing no later than March 23, 2022, and (b) recommend the re-election of Todd Stein to the Board at the 2022 Annual
Meeting.

 

2.      Representations
of the Braeside Parties. The Braeside Parties represent and warrant to the Company as of the date hereof as follows:

 

(a)            The
Braeside Parties are the beneficial owners of 1,080,127 shares of Common Stock, such shares of Common Stock constitute all of the Common
Stock beneficially owned by the Braeside Parties and the Braeside Parties have no agreements, understandings or undertakings with any
third party to share or delegate disposition or voting control over such shares of Common Stock, or to transfer, hypothecate or lend
such shares of Common Stock.

 

(b)            Each
of the Braeside Parties has the power and authority to execute and deliver this Agreement. This Agreement (i) has been duly and
validly authorized by each of the Braeside Parties and constitutes a legal, valid and binding obligation of each of the Braeside Parties
enforceable against each of the Braeside Parties in accordance with its terms except as may be limited by bankruptcy, insolvency or similar
laws affecting creditors’ rights and general equitable principles, (ii) does not require the approval of any investor in or
member of the Braeside Parties and (iii) does not violate any law, order of any court or any governmental agency or regulation or
the charter or any organizational document of the Braeside Parties, or conflict with, result in a breach of or constitute a default under
any agreement or instrument by which the Braeside Parties or any of their respective assets is bound.

 

3.      Representations
of the Company. The Company represents and warrants to the Braeside Parties as of the date hereof that it has the corporate power
and authority to execute and deliver this Agreement. This Agreement (i) has been duly and validly authorized by the Company and
constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms except
as may be limited by bankruptcy, insolvency or similar laws affecting creditors’ rights and general equitable principles and (ii) does
not violate any law, order of any court or any agency or regulation or the Company’s Certificate of Incorporation (the “Charter”)
or the Bylaws (the “Bylaws”), or conflict with, result in a breach of or constitute a default under any agreement
or instrument by which the Company or any of its assets or the assets of its subsidiaries are bound.

 

     

     

    

 

4.     Voting
Commitments. The Braeside Parties shall appear in person or by proxy for quorum purposes at the 2022 Annual Meeting, including any
adjournment or postponement thereof, to vote all of the shares of Common Stock beneficially owned by the Braeside Parties on the record
date (if the 2022 Annual Meeting is within thirty (30) days of the anniversary of the Company’s 2021 Annual Meeting of Stockholders,
such number of shares shall be no less than 90% of the Current Position) for such meeting (i) in favor of all persons nominated
by the Board to serve as directors of the Company and against any stockholder nominated candidate not endorsed by the Board, (ii) to
ratify the appointment of the Company’s independent registered public accounting firm and (iii) in accordance with the Board’s
recommendation with respect to the Company’s “say-on-pay” proposal (collectively, the “2022 Proposals”),
provided, that Braeside Parties shall have the right to vote the shares of Common Stock beneficially owned by the Braeside Parties in
their sole discretion with respect to all other proposals brought before the 2022 Annual Meeting. The Braeside Parties shall provide
written evidence of the votes made in accordance with the foregoing sentence to the Company no later than ten business days before the
2022 Annual Meeting.

 

5.      Standstill.

 

(a)            From
the date of this Agreement until the expiration of the Standstill Period (as defined below), except as specifically authorized by the
Board, each Braeside Party shall not, and shall cause its respective Affiliates, principals, directors, general partners, officers, employees
and, to the extent acting on its behalf or at its direction, agents and other representatives (collectively, the “Related
Persons”) not to, directly or indirectly:

 

(i)            make
any announcement or proposal with respect to, or offer, seek, propose or indicate an interest in (A) any form of business combination
or acquisition or other transaction relating to assets or securities of the Company or any of its subsidiaries, (B) any form of
restructuring, recapitalization or similar transaction with respect to the Company or any of its subsidiaries or (C) any form of
tender or exchange offer for shares of Common Stock, whether or not such transaction involves a Change of Control of the Company (it
being understood that the foregoing shall not prohibit Investors or their Affiliates from acquiring Common Shares by means other than
a tender or exchange offer within the limitations set forth in Section 5(c));

 

(ii)           engage
in any solicitation of proxies or written consents to vote (or withhold the vote of) any voting securities of the Company, or conduct
any binding or nonbinding referendum with respect to any voting securities of the Company, or assist or participate in any other way,
directly or indirectly, in any solicitation of proxies (or written consents) with respect to any voting securities of the Company, or
otherwise become a “participant” in a “solicitation,” as such terms are defined in Instruction 3 of Item 4 of
Schedule 14A and Rule 14a-1 of Regulation 14A, respectively, under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), to vote (or withhold the vote of) any securities of the Company;

 

(iii)          seek
to advise, encourage or influence any person with respect to the voting of (or execution of a written consent in respect of) acquisition
of or disposition of any securities of the Company;

 

(iv)          take
any action in support of or make any proposal or request that constitutes (or would constitute if taken), or make any public statement
or have a discussion with any known shareholder of the Company concerning or with the effect of: (A) advising, controlling, changing
or influencing the Board or management of the Company, including any plans or proposals to change the voting standard with respect to
director elections, number or term of directors or to fill any vacancies on the Board, except as set forth in this Agreement, (B) any
change in the capitalization, stock repurchase programs and practices, or dividend policy of the Company, (C) any other change in
the Company’s management, business, or corporate structure, (D) seeking to have the Company waive or make amendments or modifications
to the Charter or Bylaws, or other actions that may impede or facilitate the acquisition of control of the Company by any person, (E) causing
a class of securities of the Company to be delisted from, or to cease to be authorized to be quoted on, any securities exchange or (F) causing
a class of securities of the Company to become eligible for termination of registration pursuant to Section 12(g)(4) of the
Exchange Act;

 

(v)           engage
in any course of conduct with the purpose of causing stockholders of the Company to vote contrary to the recommendation of the Board
on the 2022 Proposals for their vote at any meeting of the Company’s stockholders or by written consent;

 

     

     

    

 

(vi)          call
or seek to call, or request the call of, alone or in concert with others, any meeting of stockholders, whether or not such a meeting
is permitted by the Charter or Bylaws, including any “town hall meeting”;

 

(vii)         deposit
any shares of Common Stock in any voting trust or subject any shares of Common Stock to any arrangement or agreement with respect to
the voting of any shares of Common Stock (other than any such voting trust, arrangement or agreement solely among the Investors or any
Affiliates thereof that is otherwise in accordance with this Agreement);

 

(viii)        act,
seek, facilitate or encourage any person to submit nominations or proposals, whether in furtherance of a “contested solicitation”
or otherwise, for the appointment, election or removal of directors or otherwise with respect to the Company or seek, facilitate, encourage
or take any other action with respect to the appointment, election or removal of any directors;

 

(ix)           Other
than with respect to the “group” identified on Amendment No. 1 to the Schedule 13D filed by Braeside Investments, LLC
with the Securities and Exchange Commission on April 11, 2018, join or in any other way participate in any “group” (within
the meaning of Section 13(d)(3) of the Exchange Act or otherwise) with respect to the Company or its securities; provided,
however, that nothing in this Agreement shall limit the ability of an Affiliate of the Braeside Parties to join the existing “group”
following the execution of this Agreement upon notice to the Company, so long as any such Affiliate first agrees to be bound in writing
by the terms and conditions of this Agreement (it being understood that any Schedule 13D amendment or other legally required update and
the contents thereof may not violate any of the restrictions set forth in this Agreement);

 

(x)            demand
a copy of the Company’s list of stockholders or its other books and records or make any request under Section 220 of the Delaware
General Corporation Law or equivalent state or federal laws;

 

(xi)           commence,
encourage, join as a party, or support any litigation, arbitration, derivative action in the name of the Company or any class action
or other proceeding against the Company or any of its current or former officers or directors, in each case with the intent of circumventing
the provisions of this Section 5 or Section 6, or take any action challenging the validity or enforceability
of any of the provisions of this Section 5; provided, however, that the foregoing shall not prevent any Braeside
Party from (A) bringing litigation against the Company to enforce the provisions of this Agreement, (B) making counterclaims
with respect to any proceeding initiated by or on behalf of the Company against a Braeside Party or (C) responding to or complying
with a validly issued legal process that neither the Braeside Parties nor any of their Affiliates initiated, encouraged or facilitated;
provided that the Braeside Parties shall, to the extent permitted by law, provide the Company with notice of such legal process and will
cooperate with the Company, at the Company’s sole expense, in seeking a protective order or other remedy to the extent applicable;

 

(xii)          make
any request or submit any proposal to amend or waive the terms of this Section 5 other than through non-public communications
with the Company that would not be reasonably expected to result in or involve public disclosure obligations for any party; or

 

(xiii)         enter
into any discussions, negotiations, agreements or understandings with any person or entity with respect to any action the Investors are
prohibited from taking pursuant to this Section 5, or advise, assist, knowingly encourage or seek to persuade any person
or entity to take any action or make any statement with respect to any such action, or otherwise take or cause any action or make any
statement inconsistent with any of the foregoing.

 

Notwithstanding the foregoing,
nothing in this Section 5 or elsewhere in this Agreement shall prohibit or restrict the Braeside Parties from: (x) communicating
privately with the Board or any executive officer or director of the Company, regarding any matter, so long as such communications are
not intended to, and would not reasonably be expected to, require any public disclosure of such communications and subject to the confidentiality
obligations to the Company of any such director or officer; and (y) privately communicating to any of their potential investors
or their investors publicly available information that does not otherwise violate this Agreement regarding the Company consistent with
prior practice in any of the Braeside Parties’ annual and quarterly investor letters, provided such communications are not reasonably
expected to be publicly disclosed and are understood by all parties to be private communications and not undertaken with the intent to
circumvent Section 5 of this Agreement.

 

     

     

    

 

(b)            Notwithstanding
anything set forth herein to the contrary, upon the public announcement by the Company of entry into a definitive agreement for a transaction
that would constitute a Change of Control, this Agreement shall immediately and automatically terminate in its entirety and no party
hereunder shall have any further rights or obligations under this Agreement; provided, however, no party shall be released
from any breach of this Agreement that occurred prior to the termination of this Agreement.

 

(c)            For
purposes of this Agreement:

 

(i)            “Affiliate”
shall mean any “Affiliate” as defined in Rule 12b-2 promulgated by the SEC under the Exchange Act;

 

(ii)           “Associate”
shall mean any “Associate” as defined in Rule 12b-2 promulgated by the SEC under the Exchange Act;

 

(iii)          “beneficial
owner” and “beneficial ownership” shall have the same meanings as set forth in Rule 13d-3
promulgated by the SEC under the Exchange Act;

 

(iv)          a
 “Change of Control” transaction shall be deemed to have taken place if (A) any person is or becomes a
beneficial owner, directly or indirectly, of securities of the Company representing more than 50% of the equity interests and voting
power of the Company’s then outstanding equity securities, (B) the Company effects a merger or a stock-for-stock transaction
with a third party whereby immediately after the consummation of the transaction the Company’s stockholders retain less than 50%
of the equity interests and voting power of the surviving entity’s then outstanding equity securities or (C) the Company sells
all or substantially all of the Company’s assets to a third party;

 

(v)           “person”
or “persons” shall mean any individual, corporation (including not-for-profit), general or limited partnership,
limited liability company, joint venture, estate, trust, association, organization or other entity of any kind or nature; and

 

(vi)          “Standstill
Period” shall mean the period commencing on the date of this Agreement and ending on the date that is one day after the
date of the 2022 Annual Meeting

 

6.      Mutual
Non-Disparagement.

 

(a)            Each
Braeside Party agrees that, until the expiration of the Standstill Period, neither it nor any of its Affiliates will, and it will cause
each of its Affiliates and Related Persons not to, directly or indirectly, in any capacity or manner, make, express, transmit, speak,
write, verbalize or otherwise communicate in any way (or cause, further, assist, solicit, encourage, support or participate in any of
the foregoing), any remark, comment, message, information, declaration, communication or other statement of any kind, whether verbal,
in writing, electronically transferred or otherwise, that might reasonably be construed to be derogatory towards, or critical of, the
Company or any of its past or present directors, officers, Affiliates, subsidiaries, employees, agents or representatives (collectively,
the “Company Representatives”), or that reveals, discloses, incorporates, is based upon, discusses, includes
or otherwise involves any confidential or proprietary information of the Company or its subsidiaries or Affiliates, or to malign, harm,
disparage, defame or damage the reputation or good name of the Company, any Company Representative or the Company’s business; provided,
however, that the foregoing shall not prevent the Investor Group from privately communicating to the Company, or any directors
or executive officers of the Company factual information based on publicly available information. Nothing herein or elsewhere in this
Agreement shall restrict the ability of any person to comply with any subpoena or other legal process or respond to a request for information
from any governmental authority with jurisdiction over the party from whom information is sought.

 

     

     

    

 

(b)            The
Company agrees that, until the expiration of the Standstill Period, neither it nor any of its executive officers or directors will, directly
or indirectly, in any capacity or manner, make, express, transmit, speak, write, verbalize or otherwise communicate in any way (or cause,
further, assist, solicit, encourage, support or participate in any of the foregoing), any remark, comment, message, information, declaration,
communication or other statement of any kind, whether verbal, in writing, electronically transferred or otherwise, that might reasonably
be construed to be derogatory towards, or critical of, any Braeside Party or any of its past or present directors, officers, Affiliates,
subsidiaries, employees, agents or representatives (collectively, the “Braeside Representatives”), or that
reveals, discloses, incorporates, is based upon, discusses, includes or otherwise involves any confidential or proprietary information
of any Braeside Party or its Affiliates, or to malign, harm, disparage, defame or damage the reputation or good name of any Braeside
Party, any Braeside Representative or any Braeside Party’s business; provided, however, that the foregoing shall
not prevent private communications to the Braeside Parties or Braeside Representatives of factual information based on publicly available
information. Nothing herein or elsewhere in this Agreement shall restrict the ability of any person to comply with any subpoena or other
legal process or respond to a request for information from any governmental authority with jurisdiction over the party from whom information
is sought.

 

(c)            Notwithstanding
the foregoing, nothing in this Section 6 or elsewhere in this Agreement shall prohibit any party to this Agreement from making
any statement or disclosure required under the federal securities laws or other applicable laws, rules or regulations so long as
such requirement is not due to a breach by any party of this Agreement; provided, that such party must, to the extent legally permissible
and practicable, provide written notice to the other party at least five (5) business days prior to making any such statement or
disclosure required under the federal securities laws or other applicable laws, and shall reasonably consider any comments of the other
party. The limitations set forth in Sections 6(a) and 5(b) shall not prevent any party to this Agreement
from responding to any public statement made by the other party of the nature described in Sections 6(a) and 5(b) if
such statement by the other party was made in breach of this Agreement.

 

7.      Press
Release. The Parties agree that the Company shall issue a press release and file a Current Report on Form 8-K in substantially
the forms agreed to between the Parties promptly following the execution and delivery of this Agreement by the Parties.

 

8.      Actions
as Director. Notwithstanding anything set forth herein to the contrary, this Agreement shall not limit in any respect the actions
of Todd Stein solely in his capacity as a director of the Company, recognizing that such actions are subject to such director’s
fiduciary duties to the Company and its stockholders (it being understood and agreed that neither the Braeside Parties nor any of their
respective Affiliates shall seek to do indirectly through Todd Stein (or his successor) anything that would be prohibited if done by
the Braeside Parties or any of their respective Affiliates).

 

9.      Miscellaneous.

 

(a)            Specific
Enforcement; Special Remedy. Each of the Parties agrees that the other Party would be irreparably injured in the event that any provision
of the Agreement is breached or not performed. Accordingly, it is agreed that each Party shall be entitled to temporary and permanent
injunctive relief with respect to each and any breach or purported repudiation of this Agreement by the other and to specifically enforce
strict adherence to this Agreement and the terms and provisions hereof against the other in any action instituted in a court of competent
jurisdiction, in addition to any other remedy which such aggrieved Party may be entitled to obtain. Moreover, in the event of the breach
of any of the provisions of this Agreement, timeliness in obtaining relief is of the essence.

 

(b)            Amendments;
Waiver. Neither this Agreement nor any term hereof may be changed, waived, discharged or terminated orally or in writing without
a writing signed by the Parties. No delay on the part of either Party in exercising any right, power or privilege hereunder shall operate
as a waiver thereof, nor shall any waiver on the part of either Party of any right, power or privilege hereunder operate as a waiver
of any other right, power or privilege hereunder, nor shall any single or partial exercise of any right, power or privilege hereunder,
preclude any other or further exercise thereof or the exercise of any other right, power or privilege hereunder.

 

     

     

    

 

(c)            Successors
and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and assigns of each of the parties.
This Agreement may not be assigned without the prior written consent of the other Party hereto.

 

(d)            No
Third Party Beneficiaries. Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person
or entity, other than the Parties and their respective successors and assigns, any legal or equitable right, remedy or claim under or
in respect of this Agreement and any conditions and provisions hereof being intended to be and being for the sole and exclusive benefit
of the parties hereto and their respective successors and assigns, and for the benefit of no other person or entity.

 

(e)            Counterparts.
This Agreement may be executed in any number of counterparts and by the Parties in separate counterparts, each of which when so executed
shall be deemed to be an original and all of which taken together shall constitute one and the same agreement.

 

(f)             Headings.
The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.

 

(g)            Governing
Law; Choice of Venue.

 

(i)            This
Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware applicable to agreements made
and to be performed within that state.

 

(ii)            Each
Party (A) consents to submit itself to the personal jurisdiction of the Court of Chancery or other federal or state courts of the
State of Delaware in the event any dispute arises out of this Agreement or the transactions contemplated by this Agreement, (B) agrees
that it shall not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court, (C) agrees
that it shall not bring any action relating to this Agreement or the transactions contemplated by this Agreement in any court other than
the Court of Chancery or other federal or state courts of the State of Delaware, and each Party irrevocably waives the right to trial
by jury and (D) each Party irrevocably consents to service of process by a reputable overnight mail delivery service, signature
requested, to the address of such Party’s principal place of business or as otherwise provided by applicable law.

 

(h)            Severability.
If at any time subsequent to the date hereof, any provision of this Agreement shall be held by any court of competent jurisdiction to
be illegal, void or unenforceable, such provision shall be of no force and effect, but the illegality or unenforceability of such provision
shall have no effect upon the legality or enforceability of any other provision in this Agreement.

 

(i)             Interpretation
and Construction. Each of the Parties acknowledges that it has been represented by counsel of its choice throughout all negotiations
that have preceded the execution of this Agreement, and that it has executed the same with the advice of said independent counsel. Each
Party and its counsel cooperated and participated in the drafting and preparation of this Agreement and the documents referred to herein,
and any and all drafts relating thereto exchanged among the parties shall be deemed the work product of all of the parties and may not
be construed against any Party by reason of its drafting or preparation. Accordingly, any rule of law or any legal decision that
would require interpretation of any ambiguities in this Agreement against any Party that drafted or prepared it is of no application
and is hereby expressly waived by each Party, and any controversy over interpretations of this Agreement shall be decided without regards
to events of drafting or preparation.

 

(j)             Entire
Agreement. This Agreement contains the entire understanding of the Parties with respect to the subject matter hereof.

 

     

     

    

 

(k)            Notices.
Any notices, consents, determinations, waivers or other communications required or permitted to be given under the terms of this Agreement
must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt,
when sent by e-mail to the e-mail address for a Party set forth below; and (iii) one (1) business day after deposit with a
nationally recognized overnight delivery service, in each case properly addressed to the Party to receive the same. The addresses for
such communications shall be:

 

If to the Company or the
Board:

 

Spōk Holdings, Inc.

5911 Kingstowne Village Parkway

Alexandria, VA 22315

		Attention:	Vince Kelly
	 	Email:	Vince.Kelly@spok.com

 

with a copy (which shall not constitute notice) to:

 

Latham & Watkins LLP

555 Eleventh Street, NW

Suite 1000

Washington, D.C. 20004

		Attention:	William O’Neill and
Christopher Drewry

		E-mail:	William.O'Neill@retiredpartner.lw.com
and Christopher.Drewry@lw.com

 

If to the Braeside Parties:

 

Braeside Investments, LLC

2911 Turtle Creek Boulevard

Suite 300

Dallas, TX 75219

		Attention:	Todd Stein

 

(l)             Termination.
Unless earlier terminated as provided in this Agreement, upon the expiration of the Standstill Period in accordance with Section 5,
this Agreement shall immediately and automatically terminate in its entirety and no Party shall have any further rights or obligations
under this Agreement; provided, however, no Party shall be released from any breach of this Agreement that occurred
prior to the termination of this Agreement.

 

[Signature Pages Follow]

 

     

     

    

 

IN WITNESS WHEREOF, each of the parties hereto has executed this Agreement,
or caused the same to be executed by its duly authorized representative as of the date first above written.

 

	 	SPŌK HOLDINGS, INC.
	 	 
	 	By:	/s/ Vincent D. Kelly
	 	Name:	Vincent D. Kelly
	 	Title:	Chief Executive Officer

 

[Signature
Page to Voting and Standstill Agreement]|

 

     

     

    

 

	 	BRAESIDE INVESTMENTS, LLC
	 	 
	 	By:	/s/ Todd Stein
	 	Name:	Todd Stein
	 	Title:	Manager
	 	 
	 	Braeside
                                        CAPITAL, L.P.
	 	 
	 	By:	/s/ Todd Stein
	 	Name:	Todd Stein
	 	Title:	Manager
	 	 
	 	BRAESIDE CAPITAL II, L.P.
	 	 
	 	By:	/s/ Todd Stein
	 	Name:	Todd Stein
	 	Title:	Manager

 

[Signature Page to Voting and Standstill
Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]